Analysis of 340B DSH Hospital Services Delivered to Vulnerable Patient Populations
340B Health commissioned the research firm Dobson DaVanzo & Associates to conduct an analysis of hospitals to determine the extent to which disproportionate share (DSH) hospitals participating in the 340B drug discount program are targeting their services to vulnerable patient populations. The study compared 340B DSH hospitals to DSH hospitals not in the 340B program on three metrics: (1) low-income Medicaid/Medicare SSI patient caseload, (2) uncompensated care and unreimbursed costs, and (3) provision of specialized services. The study found that 340B DSH hospital low-income patient loads are nearly twice as large as non-340B hospital low-income patient loads, 340B DSH hospitals account for about one third of all DSH hospitals but provide nearly 60 percent of all uncompensated care, and more 340B DSH hospitals than non-340B hospitals are providing specialized services that are often unprofitable.
See an executive summary, the full report, and infographics summarizing the results below.
Executive Summary
Full Report
340B DSH hospitals have significantly higher low-income patient loads than non-340B DSH hospitals and provide more uncompensated care
